Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mol Biol Rep. 2020 Jan;47(1):123-128. doi: 10.1007/s11033-019-05113-x. Epub 2019 Dec 13.
Dendritic cells (DCs) have a major role in the initiation of an immune response and Immunoglobulin-like transcript 3&4 (ILT3&ILT4) are inhibitory receptors that induce tolerance in DCs. Recent studies show that immunosuppressive agents affect frequency of DCs. Herein, we compared the effect of mycophenolate mofetil (MMF) and sirolimus (SRL) in tacrolimus (TAC)-based immunosuppression on DC subsets frequency and ILT3/ILT4 gene expression in kidney transplant recipients. We enrolled 24 adult transplant recipients who received MMF/TAC (n = 14) or SRL/TAC (n = 10). Peripheral blood samples were obtained from recipients, 24-48 h before transplantation and 4 months after transplantation. The frequency of DC subsets was analyzed by flow cytometry and gene expression of ILT3/ILT4 were estimated by real-time PCR. Our results showed that MMF vs. SRL treated recipient showed an increase in pDC % with increased in the expression of ILT3/ILT4 which is in favor of better allograft survival; However, for confirming the results of this preliminary study, a cohort study with larger sample size is necessary.
树突状细胞 (DCs) 在免疫反应的启动中起着重要作用,免疫球蛋白样转录物 3 和 4 (ILT3 和 ILT4) 是抑制性受体,可诱导 DCs 耐受。最近的研究表明,免疫抑制药物会影响 DCs 的频率。在此,我们比较了吗替麦考酚酯 (MMF) 和西罗莫司 (SRL) 在他克莫司 (TAC) 为基础的免疫抑制方案中对肾移植受者 DC 亚群频率和 ILT3/ILT4 基因表达的影响。我们纳入了 24 名接受 MMF/TAC(n=14)或 SRL/TAC(n=10)治疗的成年移植受者。在移植前 24-48 小时和移植后 4 个月从受者获得外周血样本。通过流式细胞术分析 DC 亚群的频率,通过实时 PCR 估计 ILT3/ILT4 的基因表达。我们的结果表明,与 SRL 相比,MMF 治疗的受者 pDC%增加,ILT3/ILT4 的表达增加,有利于更好的移植物存活;然而,为了确认这项初步研究的结果,需要进行更大样本量的队列研究。